Results 21 to 30 of about 321,767 (163)

Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations

Pulmonary Circulation, Volume 12, Issue 2, April 2022., 2022
Abstract Right heart thrombi (RHT) continues to pose a clinical dilemma for multiple specialties and is especially concerning when present with concomitant pulmonary embolism (PE). Patients with PE and RHT are at an increased risk of poor outcomes compared to PE without RHT. Although the exact incidence of RHT is unknown, the increasing use of point‐of‐
Akhil Khosla, Hamid Mojibian, Roland Assi, Hossam Tantawy, Inderjit Singh, Jeffrey Pollak   +5 more
wiley   +1 more source

International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis

Journal of Thrombosis and Haemostasis, Volume 19, Issue 4, Page 1123-1129, April 2021., 2021
Abstract Pediatric thromboembolism is a rare and heterogenous disease. As a result, there is a paucity of knowledge with regard to natural history, management, and outcomes of most types of pediatric venous and arterial thromboembolism. International research collaboration is needed to fill these knowledge gaps.
C. Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, Marianne Bonduel, Brian Branchford, Elizabeth Chalmers, Anthony Chan, Neil A. Goldenberg, Susanne Holzhauer, Paul Monagle, Ulrike Nowak‐Göttl, Shoshana Revel‐Vilk, Gabriela Sciuccatie, Nongnuch Sirachainan, Christoph Male, for the Subcommittee on Pediatric, Neonatal Thrombosis, Hemostasis   +17 more
wiley   +1 more source

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies

Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue 3, Page 426-438, March 2021., 2021
Abstract Background The XALIA and XALIA‐LEA prospective, noninterventional studies investigated the safety and effectiveness of rivaroxaban versus standard anticoagulation for venous thromboembolism (VTE) treatment in routine clinical practice across global regions.
Sylvia Haas, Lorenzo G. Mantovani, Reinhold Kreutz, Danja Monje, Jonas Schneider, Elizabeth R. Zell, Miriam Tamm, Martin Gebel, Jörg‐Peter Bugge, Walter Ageno, Alexander G. G. Turpie   +10 more
wiley   +1 more source

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE

Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue 2, Page 326-341, February 2021., 2021
Abstract Introduction Venous thromboembolism (VTE) has a long‐term risk of recurrence, dependent on the presence or absence of provoking risk factors at the time of the event. Objective To compare clinical characteristics, anticoagulant patterns, and 12‐month outcomes in patients with transient provoking factors, active cancer, and unprovoked VTE ...
Walter Ageno, Alfredo Farjat, Sylvia Haas, Jeffrey I. Weitz, Samuel Z. Goldhaber, Alexander G. G. Turpie, Shinya Goto, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar   +14 more
wiley   +1 more source

Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue 1, Page 168-178, January 2021., 2021
Abstract Background The optimal therapy of patients with acute subsegmental pulmonary embolism (PE) is controversial. Methods We used the RIETE (Registro Informatizado Enfermedad TromboEmbólica) database to compare the rate of symptomatic PE recurrences during anticoagulation in patients with subsegmental, segmental, or more central PEs.
Carmen Fernández‐Capitán, Ana Rodriguez Cobo, David Jiménez, Olga Madridano, Maurizio Ciammaichella, Esther Usandizaga, Remedios Otero, Pierpaolo Di Micco, Farès Moustafa, Manuel Monreal, The RIETE Investigators, M. D. Adarraga, M. A. Aibar, M. Alfonsa, J. I. Arcelus, P. Azcarate‐Agüero, A. Ballaz, P. Baños, R. Barba, M. Barrón, B. Barrón‐Andrés, J. Bascuñana, A. Blanco‐Molina, A. M. Camón, L. Chasco, A. J Cruz, R. del Pozo, J. de Miguel, J. del Toro, M. C. Díaz‐Pedroche, J. A. Díaz‐Peromingo, J. C. Escribano, C. Falgá, C. Fernández‐Aracil, M. A. Fidalgo, C. Font, L. Font, M. A. García, F. García‐Bragado, M. García‐Morillo, A. García‐Raso, A. I. García‐Sánchez, O. Gavín, I. Gaya, C. Gómez, V. Gómez, J. González, E. Grau, R. Guijarro, J. Gutiérrez, G. Hernández‐Comes, L. Hernández‐Blasco, E. Hernando, L. Jara‐Palomares, M. J. Jaras, D. Jiménez, M. D. Joya, J. Lima, P. Llamas, J. L. Lobo, R. López‐Reyes, J. B. López‐Sáez, M. A. Lorente, A. Lorenzo, M. Lumbierres, A. Maestre, P. J. Marchena, F. Martín‐Martos, M. Martín‐Romero, M. V Morales, J. A. Nieto, S. Nieto, A. Núñez, M. J. Núñez, M. Odriozola, M. C. Olivares, S. Otalora, J. M. Pedrajas, G. Pellejero, C. Pérez‐Ductor, M. L Peris, I. Pons, J. A. Porras, L. Ramírez, O. Reig, A. Riera‐Mestre, D. Riesco, A. Rivas, M. A. Rodríguez‐Dávila, V. Rosa, P. Ruiz‐Artacho, J. C. Sahuquillo, M. C. Sala‐Sainz, A. Sampériz, R. Sánchez‐Martínez, S. Soler, B. Sopeña, J. M Suriñach, C. Tolosa, M. I Torres, J. Troya, J. Trujillo‐Santos, F. Uresandi, B. Valero, R. Valle, J. Vela, L. Vela, G. Vidal, A. Villalobos, T. Vanassche, C. Vandenbriele, P. Verhamme, H. H. B. Yoo, P. Wells, J. Hirmerova, R. Malý, E. Salgado, L. Bertoletti, A. Bura‐Riviere, N. Falvo, D. Farge‐Bancel, A. Hij, I. Mahé, I. Quere, A. Braester, B. Brenner, M. Ellis, I. Tzoran, G. Antonucci, G. Barillari, F. Bilora, C. Bortoluzzi, E. Bucherini, A. Camerota, C. Cattabiani, F. Dentali, R. Duce, M. Giorgi‐Pierfranceschi, E. Grandone, E. Imbalzano, G. Lessiani, R. Maida, D. Mastroiacovo, F. Pace, R. Pesavento, M. Pesavento, R. Poggio, P. Prandoni, R. Quintavalla, A. Rocci, C. Siniscalchi, E. Tiraferri, D. Tonello, A. Visonà, B. Zalunardo, V. Gibietis, A. Skride, B. Vitola, A. Alatri, H. Bounameaux, L. Calanca, L. Mazzolai   +161 more
wiley   +1 more source

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

Clinical and Translational Science, Volume 14, Issue 1, Page 335-342, January 2021., 2021
Edoxaban is used for venous thromboembolism (VTE) treatment. Real‐life data are lacking about its use in long‐term therapy. We aimed to assess the efficacy and the safety of edoxaban for long‐term VTE treatment in a real‐life setting. Patients with VTE included in the Registro Informatizado Enfermedad TromboEmbólica (RIETE) registry, receiving edoxaban
Giuseppe Camporese, Paolo Simioni, Pierpaolo Di Micco, Carmen Fernández‐Capitán, Agustina Rivas, Carme Font, Joan Carles Sahuquillo, Paula Villares, Paolo Prandoni, Manuel Monreal, and the RIETE Investigators   +10 more
wiley   +1 more source

Profilaxis con anticoagulantes frente a enfermedad tromboembólica en pacientes sometidos a artroplastia total de rodilla

, 2023
Profilaxis con anticoagulantes frente a enfermedad tromboembólica en pacientes sometidos a artroplastia total de ...
Alvaro Rodrigo Sanhueza palma, Marcela Cortes-Jofre, Pedro Andreu, DANIEL EDUARDO CARRASCO CONTRERAS, Cristóbal Ignacio Arroyo Zambrano, Luis E. Ortiz-Muñoz   +5 more
core   +1 more source

Enfermedad tromboembólica en gatos [PDF]

, 2023
La enfermedad tromboembólica produce obstrucción de los vasos sanguíneos debido a la formación de trombos u otros agregados, que migran y se alojan en diferentes localizaciones.
Miana Mena, Francisco Javier, Aldaz Muñoz, Ana Carmen   +1 more
core  

Clinical significance of subsegmental pulmonary embolism: An ongoing controversy

, 2021
Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue 1, Page 14-16, January 2021.
Christine Baumgartner, Tobias Tritschler
wiley   +1 more source

Enfermedad tromboembólica en Obstetricia y Ginecología

Revista Colombiana de Obstetricia y Ginecología, 1997
Se realiza una revisión que comprende: los mecanismos de la hemostasia, los factores predisponentes de la enfermedad tromboembólica, los métodos diagnósticos, la profilaxis y el tratamiento de la misma.
Federación Colombiana de Obstetricia y Ginecología
doaj   +1 more source